Navigation Links
New method makes vaccines stable at tropical temperatures
Date:2/17/2010

A cheap and simple way of making vaccines stable even at tropical temperatures has been proven to work by scientists at Oxford University.

The British technology, developed by specialist manufacturer Nova Bio-Pharma Technologies, removes the need for fridges, freezers and associated health infrastructure. It has the potential to revolutionise vaccination efforts - particularly in the developing world where infectious diseases kill millions of people every year.

Oxford University carried out the proof-of-concept study on Nova's patented HydRIS (Hypodermic Rehydration Injection System) system, that creates thermally stable, instantly injectable formats. The results are due to be published in the journal Science Translational Medicine.

The team showed it was possible to store two different virus-based vaccines on sugar-stabilised membranes for 4𔃄 months at 45C without any degradation. The vaccines could be kept for a year and more at 37C with only tiny losses in the amount of viral vaccine re-obtained from the membrane. When required the membrane is then attached to a conventional syringe and flushed with liquid, with the re-dissolved product quickly and simply injected.

Preparing vaccines that do not need refrigeration has been identified as one of the major unsolved problems in global health.

Nova has now proved the potential to solve many of the problems that pharmaceutical and biotechnology companies have around stabilising the medicines of tomorrow, while offering significant practical advantages and reducing costs. Its patented technologies were also designed for ease and convenience of administration and true availability at the 'point of care'.

Dr Peter White, Nova's managing director, said the work by Oxford University demonstrated one successful application of Nova's patented HydRIS technology platform and that Nova has already successfully stabilised a wide range of viral and conventional vaccines.

"This new technique of drug delivery is one of the most exciting developments in the British pharmaceutical and biotechnology industries, especially as it can be used for highly unstable products, for instance vaccines for malaria," he said.

"The benefits it offers to our customers with many now looking for more efficient, cost-effective ways of delivering drugs - and the impact it can have abroad, cannot be overstated."

Lead author Dr Matt Cottingham of the Jenner Institute at the University of Oxford said: "Currently vaccines need to be stored in a fridge or freezer. That means you need a clinic with a nurse, a fridge and an electricity supply, and refrigeration lorries for distribution.

"If you could ship vaccines at normal temperatures, you would greatly reduce cost and hugely improve access to vaccines. You could even picture someone with a backpack taking vaccine doses on a bike into remote villages."

The research was funded by the Grand Challenges in Global Health partnership with other funds from the Wellcome Trust.

At its state-of-the-art facilities in Leicester, Nova has developed world-class expertise in aseptic processing of complex pharmaceuticals using sterile isolation technology.

Nova can handle low value/high volume production (such as mass vaccination programmes); and high value/low volume products like bio-defence/therapeutic vaccines, which require rapid deployment in a user friendly format (such as for the emergency services/armed forces).

The core principle of the HydRIS technology - the formation of sugar-glass stabiliser matrix on a fibrous membrane/surface with thermal stability - could be used as part of a diagnostic kit or device to enable usage/storage outside the cold chain, for example in medical or forensic use.

HydRIS technology could be modified for a range of other applications like oral or topical delivery of stabilised vaccines/therapeutics for both human and animal use.


'/>"/>

Contact: Andrew Rea
andy@gravitaspr.co.uk
44-012-422-11000
Gravitas PR
Source:Eurekalert  

Related biology technology :

1. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
2. Prototype NIST method detects and measures elusive hazards
3. Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM(R) Kit is a Reliable, Rapid Method for Extracting DNA From Saliva
4. Scientists develop novel method to generate functional hepatocytes for drug testing
5. ZyGEM Releases Data Confirming its prepGEM(R) Insect Kit is a Simple, Rapid Method for Extracting Insect DNA for Species Identification
6. Argonne Researchers Develop Method that Aims to Stabilize Antibodies
7. The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method
8. IIVS Announces Initiation by EPA of a Pilot Program to Evaluate Non-Animal Eye-Irritation Methods
9. Video of EpiDerm Skin Irritation Test (SIT) Method Now Available
10. New method may accelerate drug discovery for difficult diseases like Parkinsons
11. Novel method predicts impact of a covert anthrax release
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New method makes vaccines stable at tropical temperatures
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, ... could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma ... read it now. , Biomarkers are components in the blood, tissue or ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
(Date:5/16/2016)...   EyeLock LLC , a market leader of ... an IoT Center of Excellence in Austin, ... of embedded iris biometric applications. EyeLock,s iris ... security with unmatched biometric accuracy, making it the most ... EyeLock,s platform uses video technology to deliver a fast ...
Breaking Biology News(10 mins):